1. Home
  2. MRUS vs STNE Comparison

MRUS vs STNE Comparison

Compare MRUS & STNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRUS
  • STNE
  • Stock Information
  • Founded
  • MRUS 2003
  • STNE 2012
  • Country
  • MRUS Netherlands
  • STNE Cayman Islands
  • Employees
  • MRUS N/A
  • STNE N/A
  • Industry
  • MRUS Biotechnology: Pharmaceutical Preparations
  • STNE EDP Services
  • Sector
  • MRUS Health Care
  • STNE Technology
  • Exchange
  • MRUS Nasdaq
  • STNE Nasdaq
  • Market Cap
  • MRUS 2.8B
  • STNE 2.9B
  • IPO Year
  • MRUS 2016
  • STNE 2018
  • Fundamental
  • Price
  • MRUS $47.37
  • STNE $9.91
  • Analyst Decision
  • MRUS Strong Buy
  • STNE Buy
  • Analyst Count
  • MRUS 13
  • STNE 10
  • Target Price
  • MRUS $85.67
  • STNE $15.80
  • AVG Volume (30 Days)
  • MRUS 513.2K
  • STNE 5.6M
  • Earning Date
  • MRUS 02-26-2025
  • STNE 03-18-2025
  • Dividend Yield
  • MRUS N/A
  • STNE N/A
  • EPS Growth
  • MRUS N/A
  • STNE 103.39
  • EPS
  • MRUS N/A
  • STNE 1.18
  • Revenue
  • MRUS $35,932,000.00
  • STNE $2,267,378,982.00
  • Revenue This Year
  • MRUS N/A
  • STNE $20.01
  • Revenue Next Year
  • MRUS $42.15
  • STNE $13.70
  • P/E Ratio
  • MRUS N/A
  • STNE $8.58
  • Revenue Growth
  • MRUS N/A
  • STNE 13.89
  • 52 Week Low
  • MRUS $37.77
  • STNE $7.72
  • 52 Week High
  • MRUS $61.61
  • STNE $17.93
  • Technical
  • Relative Strength Index (RSI)
  • MRUS 71.36
  • STNE 61.10
  • Support Level
  • MRUS $39.67
  • STNE $8.89
  • Resistance Level
  • MRUS $41.15
  • STNE $10.21
  • Average True Range (ATR)
  • MRUS 1.71
  • STNE 0.36
  • MACD
  • MRUS 0.86
  • STNE 0.08
  • Stochastic Oscillator
  • MRUS 91.57
  • STNE 67.07

About MRUS Merus N.V.

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.

About STNE StoneCo Ltd.

StoneCo Ltd is a provider of financial technology solutions. It serves MSMBs great solutions, at fair prices, and provides the customer experience to help them manage their businesses and sell more. Its Stone Business Model combines end-to-end, cloud-based technology platforms; differentiated hyper-local and integrated distribution approaches; and white-glove, on-demand customer service. It has two segments Financial Services offers payments, digital banking, and credit solutions, focusing Ton solution mainly on micro-merchants, and Stone solution on SMBs. In Software, it offers POS and ERP solutions for different retail and services verticals, Customer Relationship Management, engagement tools, e-commerce, and Order Management System solutions, among others.

Share on Social Networks: